Major depression is highly prevalent among HIV‐positive patients (HIV pp). The prevalence
of depression ranges between 18% and 81%, depending on the population studied and the …

Background: Quality-of-life (QOL) assessment and improvement have recently been
recognized as important components of health care, in general, and mental health care, in …

Background Depression is a risk factor for nonadherence to HIV/AIDS treatment. Purpose A
meta-analysis was conducted to examine whether treatment of depression and …

Background. Elite controllers spontaneously suppress human immunodeficiency virus (HIV)
viremia but also demonstrate chronic inflammation that may increase risk of comorbid …

Background Depression consistently predicts nonadherence to human immunodeficiency
virus antiretroviral therapy, but which aspects of depression are most influential are …

Potent antiretroviral therapy (ART) has transformed HIV from a death sentence to a chronic
illness. Accordingly, the goal of HIV care has shifted from delaying death to achieving …

Little systematic research has been conducted on the extent of psychiatric disorders among
South African patients in general, and among patients living with HIV in particular. The …

Highly active antiretroviral therapy (HAART) has significantly decreased the morbidity and
mortality of persons infected with HIV. The extent of the benefits, however, is not uniform …

Secondary HIV prevention, or “positive prevention,” is concerned with reducing HIV
transmission risk behavior and optimizing the health and quality of life of people living with …

Background Depression is highly prevalent among patients newly starting antiretroviral
treatment (ART) in Malawi and many other countries. Untreated depression at ART initiation …